Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dipesh Uprety

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Clinical Lung Cancer|July 28, 2020
External Validation of AJCC Eighth Edition of Non-small-cell Lung Cancer Staging Among African AmericansDipesh Uprety, Andrew J Borgert, Alec J Fitzsimmons, et al.
Drugs in R&D|September 21, 2018
Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody-Drug ConjugateBilal H Lashari, Yazhini Vallatharasu, Lakshmi Kolandra, et al.
Anticancer Research|May 2, 2018
Cytoreductive Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma in the Targeted Therapy EraDipesh Uprety, Amir Bista, Angela L Smith, et al.
Cancer|July 10, 2024
Survival trends among patients with metastatic non-small cell lung cancer before and after the approval of immunotherapy in the United States: A Surveillance, Epidemiology, and End Results database-based studyYating Wang, Kyle Kondrat, Janak Adhikari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2020
Neoadjuvant Immunotherapy for NSCLC: Current Concepts and Future ApproachesDipesh Uprety, Sumithra J Mandrekar, Dennis Wigle, et al.
Cancer Medicine|February 5, 2025
Trends in the Incidence and Survival Outcomes in Patients With Small Cell Lung Cancer in the United States: An Analysis of the SEER DatabaseDipesh Uprety, Randell Seaton, Abesh Niroula, et al.
Clinical Lung Cancer|July 10, 2019
Durable Response After 2 Doses of Pembrolizumab in a Patient With Non-Small-Cell Lung Cancer With an Isolated Brain MetastasisDipesh Uprety, Lubina Arjyal, Yazhini Vallatharasu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 17, 2018
A US Registry-Based Assessment of Use and Impact of Chemotherapy in Stage I HER2-Positive Breast CancerBenjamin M Parsons, Dipesh Uprety, Angela L Smith, et al.
Acta Oncologica (Stockholm, Sweden)|October 24, 2017
The risk of second primary malignancy in patients with stage Ia non-small cell lung cancer: a U.S. population-based studyAmit Khanal, Bilal Haider Lashari, Sreechandralekha Kruthiventi, et al.
Clinical Lung Cancer|November 21, 2025
Impact of Histology and PD-L1 Status on Immune Checkpoint Inhibitors in the Treatment of Non-Small Cell Lung Cancer a Systemic Review and Meta-analysisKhalil Choucair, Hyejeong Jang, Shadia I Jalal, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Clinical Lung Cancer|July 28, 2020
External Validation of AJCC Eighth Edition of Non-small-cell Lung Cancer Staging Among African AmericansDipesh Uprety, Andrew J Borgert, Alec J Fitzsimmons, et al.
Drugs in R&D|September 21, 2018
Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody-Drug ConjugateBilal H Lashari, Yazhini Vallatharasu, Lakshmi Kolandra, et al.
Anticancer Research|May 2, 2018
Cytoreductive Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma in the Targeted Therapy EraDipesh Uprety, Amir Bista, Angela L Smith, et al.
Cancer|July 10, 2024
Survival trends among patients with metastatic non-small cell lung cancer before and after the approval of immunotherapy in the United States: A Surveillance, Epidemiology, and End Results database-based studyYating Wang, Kyle Kondrat, Janak Adhikari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2020
Neoadjuvant Immunotherapy for NSCLC: Current Concepts and Future ApproachesDipesh Uprety, Sumithra J Mandrekar, Dennis Wigle, et al.
Cancer Medicine|February 5, 2025
Trends in the Incidence and Survival Outcomes in Patients With Small Cell Lung Cancer in the United States: An Analysis of the SEER DatabaseDipesh Uprety, Randell Seaton, Abesh Niroula, et al.
Clinical Lung Cancer|July 10, 2019
Durable Response After 2 Doses of Pembrolizumab in a Patient With Non-Small-Cell Lung Cancer With an Isolated Brain MetastasisDipesh Uprety, Lubina Arjyal, Yazhini Vallatharasu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 17, 2018
A US Registry-Based Assessment of Use and Impact of Chemotherapy in Stage I HER2-Positive Breast CancerBenjamin M Parsons, Dipesh Uprety, Angela L Smith, et al.
Acta Oncologica (Stockholm, Sweden)|October 24, 2017
The risk of second primary malignancy in patients with stage Ia non-small cell lung cancer: a U.S. population-based studyAmit Khanal, Bilal Haider Lashari, Sreechandralekha Kruthiventi, et al.
Clinical Lung Cancer|November 21, 2025
Impact of Histology and PD-L1 Status on Immune Checkpoint Inhibitors in the Treatment of Non-Small Cell Lung Cancer a Systemic Review and Meta-analysisKhalil Choucair, Hyejeong Jang, Shadia I Jalal, et al.
Pageof 7